+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genital Herpes Treatment Market by Molecule, Therapy Model, Distribution Channel, Route of Administration, End User, Indication - Global Forecast to 2030- Product Image
Genital Herpes Treatment Market by Molecule, Therapy Model, Distribution Channel, Route of Administration, End User, Indication - Global Forecast to 2030- Product Image
Sale

Genital Herpes Treatment Market by Molecule, Therapy Model, Distribution Channel, Route of Administration, End User, Indication - Global Forecast to 2030

  • PDF Icon

    Report

  • 182 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6016198
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The genital herpes treatment market is undergoing significant transformation as pharmaceutical innovation, patient engagement tools, and evolving regulatory policies intersect. Senior stakeholders face a rapidly changing landscape, prompting a need for actionable intelligence and clear market orientation.

Market Snapshot: Genital Herpes Treatment Market

The Genital Herpes Treatment Market grew from USD 2.17 billion in 2024 to USD 2.28 billion in 2025. It is expected to continue growing at a CAGR of 4.93%, reaching USD 2.90 billion by 2030. This trajectory reflects increased awareness, advances in therapy, and strategic responses to evolving healthcare needs around the world.

Scope & Segmentation

This report provides a structured view of the market, analyzing core segments and emerging trends with a focus on decision-making relevance.

  • Molecule: Acyclovir, Famciclovir, Valacyclovir; available in both branded and generic forms.
  • Therapy Model: Episodic Therapy, Prophylactic Therapy, Suppressive Therapy.
  • Distribution Channel: Hospital Pharmacy (private and public), Online Pharmacy (manufacturer direct and third-party e-retailer), Retail Pharmacy (chain and independent).
  • Route Of Administration: Intravenous (home infusion and hospital), Oral (capsules, liquid, tablets), Topical (cream, ointment).
  • End User: Homecare Settings (nurse-administered, self-administered), Hospitals (private, public), Specialty Clinics (dermatology, STD clinics).
  • Indication: Asymptomatic Shedding, Primary Infection (adults, pediatrics), Recurrent Episodes (first recurrence, multiple recurrences).
  • Geography: Americas, Europe, Middle East & Africa, Asia-Pacific; including detailed country-level coverage such as United States, Germany, India, China, Brazil, and others.
  • Leading Companies: GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd, Sandoz International GmbH, Viatris Inc, Hikma Pharmaceuticals plc, Dr. Reddy's Laboratories Ltd, Sun Pharmaceutical Industries Ltd, Lupin Limited, Aurobindo Pharma Limited, Cipla Limited.

Throughout the report, secondary keyword elements highlight distribution strategy, antiviral therapy, and patient-centric pharmaceutical innovation for strategic depth.

Key Takeaways for Market Strategy

  • Scientific progress is continually refining treatment efficacy and patient adherence, leading to more differentiated products and therapeutic pathways.
  • Telemedicine solutions and digital therapeutics are expanding access and enabling personalized therapy adjustments, changing how patients and providers manage genital herpes.
  • Segmentation by molecule, route, and indication allows targeted product development and commercialization based on evolving clinical and economic needs.
  • Regional differences in reimbursement models, healthcare infrastructure, and regulatory approaches shape commercialization strategies and market prioritization.
  • The competitive landscape is shaped by both entrenched multinational pharmaceutical companies and agile specialty biotech firms driving targeted R&D, including collaborations that accelerate clinical timelines and enhance product pipelines.
  • Stakeholder interest in real-world evidence and value-based contracting is shifting pricing and access negotiations, underlining the need for sustained data generation efforts.

Assessing the Tariff Impact

Anticipated United States tariff changes in 2025 influence sourcing and pricing structures across the genital herpes treatment market. Manufacturers are responding by reconfiguring supply chains, entering long-term supplier agreements, and streamlining operations to offset cost increases. These actions demonstrate a flexible and resilient approach, ensuring continuity of supply to end users and adapting to evolving trade policy headwinds.

Methodology & Data Sources

The report leverages primary research, including interviews with leading opinion leaders, clinicians, and payor representatives, alongside secondary data such as clinical publications, regulatory filings, and patent databases. Rigorous validation through surveys and proprietary sources ensures that every insight meets high standards for reliability and replicability.

Why This Report Matters

  • Guides strategic decision-making for portfolio management and product launches in the context of dynamic patient needs and regulatory frameworks.
  • Enables identification of growth opportunities by mapping regional adoption patterns, technology uptake, and reimbursement dynamics.
  • Equips leaders to align market entry strategies and commercial operations with long-term industry shifts from both clinical and economic perspectives.

Conclusion

The genital herpes treatment market offers substantial opportunities for differentiation through science, technology, and agile operational strategies. Leaders leveraging deep segmentation, regional insights, and adaptive supply approaches position themselves for sustainable growth and impactful patient outcomes.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Genital Herpes Treatment Market, by Molecule
8.1. Introduction
8.2. Acyclovir
8.2.1. Branded
8.2.2. Generic
8.3. Famciclovir
8.3.1. Branded
8.3.2. Generic
8.4. Valacyclovir
8.4.1. Branded
8.4.2. Generic
9. Genital Herpes Treatment Market, by Therapy Model
9.1. Introduction
9.2. Episodic Therapy
9.3. Prophylactic Therapy
9.4. Suppressive Therapy
10. Genital Herpes Treatment Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacy
10.2.1. Private Hospital Pharmacy
10.2.2. Public Hospital Pharmacy
10.3. Online Pharmacy
10.3.1. Manufacturer Direct
10.3.2. Third Party E-retailer
10.4. Retail Pharmacy
10.4.1. Chain Pharmacy
10.4.2. Independent Pharmacy
11. Genital Herpes Treatment Market, by Route of Administration
11.1. Introduction
11.2. Intravenous
11.2.1. Home Infusion
11.2.2. Hospital Administration
11.3. Oral
11.3.1. Capsules
11.3.2. Liquid
11.3.3. Tablets
11.4. Topical
11.4.1. Cream
11.4.2. Ointment
12. Genital Herpes Treatment Market, by End User
12.1. Introduction
12.2. Homecare Settings
12.2.1. Nurse-administered
12.2.2. Self-administered
12.3. Hospitals
12.3.1. Private
12.3.2. Public
12.4. Specialty Clinics
12.4.1. Dermatology Clinics
12.4.2. STD Clinics
13. Genital Herpes Treatment Market, by Indication
13.1. Introduction
13.2. Asymptomatic Shedding
13.3. Primary Infection
13.3.1. Adults
13.3.2. Pediatrics
13.4. Recurrent Episodes
13.4.1. First Recurrence
13.4.2. Multiple Recurrences
14. Americas Genital Herpes Treatment Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Genital Herpes Treatment Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Genital Herpes Treatment Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. GlaxoSmithKline plc
17.3.2. Teva Pharmaceutical Industries Ltd
17.3.3. Sandoz International GmbH
17.3.4. Viatris Inc
17.3.5. Hikma Pharmaceuticals plc
17.3.6. Dr. Reddy's Laboratories Ltd
17.3.7. Sun Pharmaceutical Industries Ltd
17.3.8. Lupin Limited
17.3.9. Aurobindo Pharma Limited
17.3.10. Cipla Limited
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. GENITAL HERPES TREATMENT MARKET MULTI-CURRENCY
FIGURE 2. GENITAL HERPES TREATMENT MARKET MULTI-LANGUAGE
FIGURE 3. GENITAL HERPES TREATMENT MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY MOLECULE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY MOLECULE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY THERAPY MODEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY THERAPY MODEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 18. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC GENITAL HERPES TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC GENITAL HERPES TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. GENITAL HERPES TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. GENITAL HERPES TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. GENITAL HERPES TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY MOLECULE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY ACYCLOVIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY BRANDED, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY GENERIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY ACYCLOVIR, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY FAMCICLOVIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY BRANDED, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY GENERIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY FAMCICLOVIR, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY VALACYCLOVIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY BRANDED, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY GENERIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY VALACYCLOVIR, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY THERAPY MODEL, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY EPISODIC THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY PROPHYLACTIC THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY SUPPRESSIVE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY PRIVATE HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY PUBLIC HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY MANUFACTURER DIRECT, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY THIRD PARTY E-RETAILER, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY HOME INFUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITAL ADMINISTRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY CREAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY OINTMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY NURSE-ADMINISTERED, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY SELF-ADMINISTERED, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY PRIVATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY PUBLIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY STD CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY ASYMPTOMATIC SHEDDING, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY PRIMARY INFECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY PRIMARY INFECTION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY RECURRENT EPISODES, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY FIRST RECURRENCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY MULTIPLE RECURRENCES, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL GENITAL HERPES TREATMENT MARKET SIZE, BY RECURRENT EPISODES, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY MOLECULE, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY ACYCLOVIR, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY FAMCICLOVIR, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY VALACYCLOVIR, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY THERAPY MODEL, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY PRIMARY INFECTION, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY RECURRENT EPISODES, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS GENITAL HERPES TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY MOLECULE, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY ACYCLOVIR, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY FAMCICLOVIR, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY VALACYCLOVIR, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY THERAPY MODEL, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 107. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 109. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 110. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 111. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 112. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY PRIMARY INFECTION, 2018-2030 (USD MILLION)
TABLE 113. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY RECURRENT EPISODES, 2018-2030 (USD MILLION)
TABLE 114. UNITED STATES GENITAL HERPES TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 115. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY MOLECULE, 2018-2030 (USD MILLION)
TABLE 116. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY ACYCLOVIR, 2018-2030 (USD MILLION)
TABLE 117. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY FAMCICLOVIR, 2018-2030 (USD MILLION)
TABLE 118. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY VALACYCLOVIR, 2018-2030 (USD MILLION)
TABLE 119. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY THERAPY MODEL, 2018-2030 (USD MILLION)
TABLE 120. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 121. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 122. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 123. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 124. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 125. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 126. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 127. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 128. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 130. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 131. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 132. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 133. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY PRIMARY INFECTION, 2018-2030 (USD MILLION)
TABLE 134. CANADA GENITAL HERPES TREATMENT MARKET SIZE, BY RECURRENT EPISODES, 2018-2030 (USD MILLION)
TABLE 135. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY MOLECULE, 2018-2030 (USD MILLION)
TABLE 136. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY ACYCLOVIR, 2018-2030 (USD MILLION)
TABLE 137. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY FAMCICLOVIR, 2018-2030 (USD MILLION)
TABLE 138. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY VALACYCLOVIR, 2018-2030 (USD MILLION)
TABLE 139. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY THERAPY MODEL, 2018-2030 (USD MILLION)
TABLE 140. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 141. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 142. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 143. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 144. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 145. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 146. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 147. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 148. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 150. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 151. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 152. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 153. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY PRIMARY INFECTION, 2018-2030 (USD MILLION)
TABLE 154. MEXICO GENITAL HERPES TREATMENT MARKET SIZE, BY RECURRENT EPISODES, 2018-2030 (USD MILLION)
TABLE 155. BRAZIL GENITAL HERPES TREATMENT MARKET SIZE, BY MOLECULE, 2018-2030 (USD MILLION)
TABLE 156. BRAZIL GENITAL HERPES TREATMENT MARKET SIZE, BY ACYCLOVIR, 2018-2030 (USD MILLION)
TABLE 157. BRAZIL GENITAL HERPES TREATMENT MARKET SIZE, BY FAMCICLOVIR, 2018-2030 (USD MILLION)
TABLE 158. BRAZIL GENITAL HERPES TREATMENT MARKET SIZE, BY VALACYCLOVIR, 2018-2030 (USD MILLION)
TABLE 159. BRAZIL GENITAL HERPES TREATMENT MARKET SIZE, BY THERAPY MODEL, 2018-2030 (USD MILLION)
TABLE 160. BRAZIL GENITAL HERPES TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 161. BRAZIL GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 162. BRAZIL GENITAL HERPES TREATMENT MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 163. BRAZIL GENITAL HERPES TREATMENT MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 164. BRAZIL GENITAL HERPES TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 165. BRAZIL GENITAL HERPES TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 166. BRAZIL GENITAL HERPES TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 167. BRAZIL GENITAL HERPES TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 168. BRAZIL GENITAL HERPES TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 169. BRAZIL GENITAL HERPES TREATMENT MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 170. BRAZIL GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 171. BRAZIL GENITAL HERPES TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 172. BRAZIL GENITAL HERPES TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 173. BRAZIL GENITAL HERPES TREATMENT MARKET SIZE, BY PRIMARY INFECTION, 2018-2030 (USD MILLION)
TABLE 174. BRAZIL GENITAL HERPES TREATMENT MARKET SIZE, BY RECURRENT EPISODES, 2018-2030 (USD MILLION)
TABLE 175. ARGENTINA GENITAL HERPES TREATMENT MARKET SIZE, BY MOLECULE, 2018-2030 (USD MILLION)
TABLE 176. ARGENTINA GENITAL HERPES TREATMENT MARKET SIZE, BY ACYCLOVIR, 2018-2030 (USD MILLION)
TABLE 177. ARGENTINA GENITAL HERPES TREATMENT MARKET SIZE, BY FAMCICLOVIR, 2018-2030 (USD MILLION)
TABLE 178. ARGENTINA GENITAL HERPES TREATMENT MARKET SIZE, BY VALACYCLOVIR, 2018-2030 (USD MILLION)
TABLE 179. ARGENTINA GENITAL HERPES TREATMENT MARKET SIZE, BY THERAPY MODEL, 2018-2030 (USD MILLION)
TABLE 180. ARGENTINA GENITAL HERPES TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 181. ARGENTINA GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 182. ARGENTINA GENITAL HERPES TREATMENT MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 183. ARGENTINA GENITAL HERPES TREATMENT MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 184. ARGENTINA GENITAL HERPES TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 185. ARGENTINA GENITAL HERPES TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 186. ARGENTINA GENITAL HERPES TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 187. ARGENTINA GENITAL HERPES TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 188. ARGENTINA GENITAL HERPES TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 189. ARGENTINA GENITAL HERPES TREATMENT MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 190. ARGENTINA GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 191. ARGENTINA GENITAL HERPES TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 192. ARGENTINA GENITAL HERPES TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 193. ARGENTINA GENITAL HERPES TREATMENT MARKET SIZE, BY PRIMARY INFECTION, 2018-2030 (USD MILLION)
TABLE 194. ARGENTINA GENITAL HERPES TREATMENT MARKET SIZE, BY RECURRENT EPISODES, 2018-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY MOLECULE, 2018-2030 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY ACYCLOVIR, 2018-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY FAMCICLOVIR, 2018-2030 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY VALACYCLOVIR, 2018-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY THERAPY MODEL, 2018-2030 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY PRIMARY INFECTION, 2018-2030 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY RECURRENT EPISODES, 2018-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA GENITAL HERPES TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 216. UNITED KINGDOM GENITAL HERPES TREATMENT MARKET SIZE, BY MOLECULE, 2018-2030 (USD MILLION)
TABLE 217. UNITED KINGDOM GENITAL HERPES TREATMENT MARKET SIZE, BY ACYCLOVIR, 2018-2030 (USD MILLION)
TABLE 218. UNITED KINGDOM GENITAL HERPES TREATMENT MARKET SIZE, BY FAMCICLOVIR, 2018-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM GENITAL HERPES TREATMENT MARKET SIZE, BY VALACYCLOVIR, 2018-2030 (USD MILLION)
TABLE 220. UNITED KINGDOM GENITAL HERPES TREATMENT MARKET SIZE, BY THERAPY MODEL, 2018-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM GENITAL HERPES TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 222. UNITED KINGDOM GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM GENITAL HERPES TREATMENT MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 224. UNITED KINGDOM GENITAL HERPES TREATMENT MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM GENITAL HERPES TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 226. UNITED KINGDOM GENITAL HERPES TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM GENITAL HERPES TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 228. UNITED KINGDOM GENITAL HERPES TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM GENITAL HERPES TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 230. UNITED KINGDOM GENITAL HERPES TREATMENT MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM GENITAL HERPES TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM GENITAL HERPES TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM GENITAL HERPES TREATMENT MARKET SIZE, BY PRIMARY INFECTION, 2018-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM GENITAL HERPES TREATMENT MARKET SIZE, BY RECURRENT EPISODES, 2018-2030 (USD MILLION)
TABLE 236. GERMANY GENITAL HERPES TREATMENT MARKET SIZE, BY MOLECULE, 2018-2030 (USD MILLION)
TABLE 237. GERMANY GENITAL HERPES TREATMENT MARKET SIZE, BY ACYCLOVIR, 2018-2030 (USD MILLION)
TABLE 238. GERMANY GENITAL HERPES TREATMENT MARKET SIZE, BY FAMCICLOVIR, 2018-2030 (USD MILLION)
TABLE 239. GERMANY GENITAL HERPES TREATMENT MARKET SIZE, BY VALACYCLOVIR, 2018-2030 (USD MILLION)
TABLE 240. GERMANY GENITAL HERPES TREATMENT MARKET SIZE, BY THERAPY MODEL, 2018-2030 (USD MILLION)
TABLE 241. GERMANY GENITAL HERPES TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 242. GERMANY GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 243. GERMANY GENITAL HERPES TREATMENT MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 244. GERMANY GENITAL HERPES TREATMENT MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 245. GERMANY GENITAL HERPES TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 246. GERMANY GENITAL HERPES TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 247. GERMANY GENITAL HERPES TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 248. GERMANY GENITAL HERPES TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 249. GERMANY GENITAL HERPES TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 250. GERMANY GENITAL HERPES TREATMENT MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 251. GERMANY GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 252. GERMANY GENITAL HERPES TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 253. GERMANY GENITAL HERPES TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 254. GERMANY GENITAL HERPES TREATMENT MARKET SIZE, BY PRIMARY INFECTION, 2018-2030 (USD MILLION)
TABLE 255. GERMANY GENITAL HERPES TREATMENT MARKET SIZE, BY RECURRENT EPISODES, 2018-2030 (USD MILLION)
TABLE 256. FRANCE GENITAL HERPES TREATMENT MARKET SIZE, BY MOLECULE, 2018-2030 (USD MILLION)
TABLE 257. FRANCE GENITAL HERPES TREATMENT MARKET SIZE, BY ACYCLOVIR, 2018-2030 (USD MILLION)
TABLE 258. FRANCE GENITAL HERPES TREATMENT MARKET SIZE, BY FAMCICLOVIR, 2018-2030 (USD MILLION)
TABLE 259. FRANCE GENITAL HERPES TREATMENT MARKET SIZE, BY VALACYCLOVIR, 2018-2030 (USD MILLION)
TABLE 260. FRANCE GENITAL HERPES TREATMENT MARKET SIZE, BY THERAPY MODEL, 2018-2030 (USD MILLION)
TABLE 261. FRANCE GENITAL HERPES TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 262. FRANCE GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 263. FRANCE GENITAL HERPES TREATMENT MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 264. FRANCE GENITAL HERPES TREATMENT MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 265. FRANCE GENITAL HERPES TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 266. FRANCE GENITAL HERPES TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 267. FRANCE GENITAL HERPES TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 268. FRANCE GENITAL HERPES TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 269. FRANCE GENITAL HERPES TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 270. FRANCE GENITAL HERPES TREATMENT MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 271. FRANCE GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 272. FRANCE GENITAL HERPES TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 273. FRANCE GENITAL HERPES TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 274. FRANCE GENITAL HERPES TREATMENT MARKET SIZE, BY PRIMARY INFECTION, 2018-2030 (USD MILLION)
TABLE 275. FRANCE GENITAL HERPES TREATMENT MARKET SIZE, BY RECURRENT EPISODES, 2018-2030 (USD MILLION)
TABLE 276. RUSSIA GENITAL HERPES TREATMENT MARKET SIZE, BY MOLECULE, 2018-2030 (USD MILLION)
TABLE 277. RUSSIA GENITAL HERPES TREATMENT MARKET SIZE, BY ACYCLOVIR, 2018-2030 (USD MILLION)
TABLE 278. RUSSIA GENITAL HERPES TREATMENT MARKET SIZE, BY FAMCICLOVIR, 2018-2030 (USD MILLION)
TABLE 279. RUSSIA GENITAL HERPES TREATMENT MARKET SIZE, BY VALACYCLOVIR, 2018-2030 (USD MILLION)
TABLE 280. RUSSIA GENITAL HERPES TREATMENT MARKET SIZE, BY THERAPY MODEL, 2018-2030 (USD MILLION)
TABLE 281. RUSSIA GENITAL HERPES TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 282. RUSSIA GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 283. RUSSIA GENITAL HERPES TREATMENT MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 284. RUSSIA GENITAL HERPES TREATMENT MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 285. RUSSIA GENITAL HERPES TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 286. RUSSIA GENITAL HERPES TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 287. RUSSIA GENITAL HERPES TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 288. RUSSIA GENITAL HERPES TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 289. RUSSIA GENITAL HERPES TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 290. RUSSIA GENITAL HERPES TREATMENT MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 291. RUSSIA GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 292. RUSSIA GENITAL HERPES TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 293. RUSSIA GENITAL HERPES TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 294. RUSSIA GENITAL HERPES TREATMENT MARKET SIZE, BY PRIMARY INFECTION, 2018-2030 (USD MILLION)
TABLE 295. RUSSIA GENITAL HERPES TREATMENT MARKET SIZE, BY RECURRENT EPISODES, 2018-2030 (USD MILLION)
TABLE 296. ITALY GENITAL HERPES TREATMENT MARKET SIZE, BY MOLECULE, 2018-2030 (USD MILLION)
TABLE 297. ITALY GENITAL HERPES TREATMENT MARKET SIZE, BY ACYCLOVIR, 2018-2030 (USD MILLION)
TABLE 298. ITALY GENITAL HERPES TREATMENT MARKET SIZE, BY FAMCICLOVIR, 2018-2030 (USD MILLION)
TABLE 299. ITALY GENITAL HERPES TREATMENT MARKET SIZE, BY VALACYCLOVIR, 2018-2030 (USD MILLION)
TABLE 300. ITALY GENITAL HERPES TREATMENT MARKET SIZE, BY THERAPY MODEL, 2018-2030 (USD MILLION)
TABLE 301. ITALY GENITAL HERPES TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 302. ITALY GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 303. ITALY GENITAL HERPES TREATMENT MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 304. ITALY GENITAL HERPES TREATMENT MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 305. ITALY GENITAL HERPES TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 306. ITALY GENITAL HERPES TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2030 (USD MILLION)
TABLE 307. ITALY GENITAL HERPES TREATMENT MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 308. ITALY GENITAL HERPES TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 309. ITALY GENITAL HERPES TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 310. ITALY GENITAL HERPES TREATMENT MARKET SIZE, BY HOMECARE SETTINGS, 2018-2030 (USD MILLION)
TABLE 311. ITALY GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 312. ITALY GENITAL HERPES TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 313. ITALY GENITAL HERPES TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 314. ITALY GENITAL HERPES TREATMENT MARKET SIZE, BY PRIMARY INFECTION, 2018-2030 (USD MILLION)
TABLE 315. ITALY GENITAL HERPES TREATMENT MARKET SIZE, BY RECURRENT EPISODES, 2018-2030 (USD MILLION)
TABLE 316. SPAIN GENITAL HERPES TREATMENT MARKET SIZE, BY MOLECULE, 2018-2030 (USD MILLION)
TABLE 317. SPAIN GENITAL HERPES TREATMENT MARKET SIZE, BY ACYCLOVIR, 2018-2030 (USD MILLION)
TABLE 318. SPAIN GENITAL HERPES TREATMENT MARKET SIZE, BY FAMCICLOVIR, 2018-2030 (USD MILLION)
TABLE 319. SPAIN GENITAL HERPES TREATMENT MARKET SIZE, BY VALACYCLOVIR, 2018-2030 (USD MILLION)
TABLE 320. SPAIN GENITAL HERPES TREATMENT MARKET SIZE, BY THERAPY MODEL, 2018-2030 (USD MILLION)
TABLE 321. SPAIN GENITAL HERPES TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 322. SPAIN GENITAL HERPES TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 323. SPAIN GENITAL HERPES TREAT

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Genital Herpes Treatment market report include:
  • GlaxoSmithKline plc
  • Teva Pharmaceutical Industries Ltd
  • Sandoz International GmbH
  • Viatris Inc
  • Hikma Pharmaceuticals plc
  • Dr. Reddy's Laboratories Ltd
  • Sun Pharmaceutical Industries Ltd
  • Lupin Limited
  • Aurobindo Pharma Limited
  • Cipla Limited

Table Information

Report AttributeDetails
No. of Pages182
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.28 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.9 Billion
Compound Annual Growth Rate4.9%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Genital Herpes Market Report 2025 - Product Image

Genital Herpes Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Herpes Simplex Epidemiology Forecast 2025-2034 - Product Image

Herpes Simplex Epidemiology Forecast 2025-2034

  • Report
  • 150 Pages
  • Global
From
Genital Herpes - Pipeline Insight, 2025 - Product Image

Genital Herpes - Pipeline Insight, 2025

  • Clinical Trials
  • 80 Pages
  • Global
From
Herpes Simplex - Pipeline Insight, 2025 - Product Image

Herpes Simplex - Pipeline Insight, 2025

  • Drug Pipelines
  • 75 Pages
  • Global
From
Herpes Simplex Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035 - Product Image

Herpes Simplex Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035

  • Report
  • 100 Pages
  • Global
From

About the Market

The Genital Herpes Drug market is a subset of the larger Infectious Diseases Drugs market. Genital Herpes is a sexually transmitted infection caused by the herpes simplex virus (HSV). Treatment for genital herpes includes antiviral medications, which can reduce the severity and duration of symptoms. These drugs can also reduce the risk of transmitting the virus to others. Commonly prescribed medications include acyclovir, valacyclovir, and famciclovir. These drugs are available in both oral and topical forms. The Genital Herpes Drug market is highly competitive, with many companies offering similar products. Major players in the market include GlaxoSmithKline, Novartis, Merck, Pfizer, and Sanofi. Other companies include Mylan, Teva Pharmaceuticals, and Cipla. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.